by Jordana Choucair | Aug 26, 2022 | Life Sciences
Pfizer Inc. said its vaccine to protect older adults against the respiratory syncytial virus (RSV) effectively reduced severe cases of the illness by nearly 86 percent. The drugmaker, which views the RSVpreF vaccine as a critical offering in its lineup of experimental...
by Jordana Choucair | Aug 26, 2022 | Life Sciences
The White House released a policy guidance requiring academic journals to provide access to papers that are publicly funded. The policy would end an optional 12-month publication embargo allowing journals to put work behind a yearlong paywall. The Office of Science...
by Jordana Choucair | Aug 26, 2022 | Payers
The Kaiser Family Foundation (KFF) released three briefs examining various aspects of Medicare Advantage (MA). The first brief analyzes the latest data on MA enrollment, revealing that nearly half of eligible Medicare beneficiaries – 28.4 million out of 58.6 million...
by Jordana Choucair | Aug 26, 2022 | Payers
A study published in JAMA Open Network found spending discrepancies between Medicare Advantage (MA) enrollees and those enrolled in a Medicare Shared Savings Program (MSSP). Based on an evaluation of 15,763 patients at Ochsner Health System, the authors found that...
by Jordana Choucair | Aug 26, 2022 | Payers
The Brookings Institution released a brief estimating that as many as 4.1 million people may remain out of work due to long COVID symptoms. The estimate is more than twice the think tank’s previous estimate of 1.6 million, released in January 2022. According to the...
by Jordana Choucair | Aug 26, 2022 | Transition to Value
The Centers for Medicare & Medicaid Services (CMS) issued a final rule that indefinitely delays the radiation oncology payment model. The payment model intended to reimburse oncology practices and outpatient sites for a total episode of care and to develop...
Recent Comments